Community post

The National Institute of Allergy and Infectious Diseases (NIAID) has begun a clinical trial for phage therapy in adults with cystic fibrosis, under the leadership of IPATH. The trial plans to enroll 72 participants across 16 cystic fibrosis centers throughout the United States. NIH press release | ClinicalTrials.gov | IPATH's FAQ on the trial